SAN FRANCISCO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The best reuse/rehab project in ...
An examination of key data privacy and cybersecurity developments in 2024 and emerging trends and risks for 2025, including information on federal and state regulatory guidance and enforcement. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results